Lumigan

Product manufactured by Allergan, Inc.

Application Nr Approved Date Route Status External Links
NDA022184 None Ophthalmic None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Lumigan ® (Bimatoprost Ophthalmic Solution) 0.01% Is Indicated For The Reduction Of Elevated Intraocular Pressure In Patients With Open Angle Glaucoma Or Ocular Hypertension. Lumigan ® 0.01% Is A Prostaglandin Analog Indicated For The Reduction Of Elevated Intraocular Pressure In Patients With Open Angle Glaucoma Or Ocular Hypertension. ( 1 )

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Bimatoprost BIMATOPROST ZINC4474405

Comments